The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...

Dec 6 (Reuters) - Regeneron (REGN.O), opens new tab said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the disease in previously untreated patients ...

Keeley Wettan is succeeding Deborah Telman, who stepped down in November for reasons the company didn't explain.

[indiscernible] of Citi Global Healthcare Conference. My name is Geoff Meacham, I'm the senior biopharma analyst here. We're thrilled today to have Regeneron. And speaking on behalf of Regeneron, we ...

Good afternoon, everybody. My name is Cory Kasimov, one of the senior biotech analysts here at Evercore ISI. And it's my pleasure to host our next discussion with Regeneron. We're fortunate to have ...

A Massachusetts woman gained two long-lost sisters through a DNA test — then tried to net a fortune when she sued them a month later over a malpractice settlement involving their dad. Carmen Thomas, ...

When Carmen Thomas was growing up in Boston, her mom told her that her absent dad’s name was Joe Brown. So when she sent a saliva sample to 23andMe in her 20s and got a match with a Brown, she was ...

Most people take a 23andMe or AncestryDNA test for fun. Maybe you want to confirm an Irish ancestry or learn something about your health. Well, that’s what you think. What you don’t expect is a ...